Treatment of vasculitic peripheral neuropathy: A retrospective analysis of outcome

QJM: An International Journal of Medicine

Volumn 100, Issue 1, 2007, Pages 41-51

  Mathew, L ^a   Talbot, K ^b   Love, S ^c   Puvanarajah, S ^b   Donaghy, M ^a,b  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PROSTACYCLIN; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONONEUROPATHY; MONONEUROPATHY MULTIPLEX; MONOTHERAPY; MORTALITY; NERVE BIOPSY; NEUTROPENIA; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; RECURRENCE RISK; REMISSION; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC VASCULITIS; TREATMENT RESPONSE; VASCULITIS;

EID: 33845911238     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl125     Document Type: Article

References (35)

1. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 2004; 30:131-56.
2. Moore PM, Fauci AS. Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. Am J Med 1981; 71:517-24.
3. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990; 33:1065-7.
4. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
5. Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med 1967; 43:8-14.
6. Moore PM, Cupps TR. Neurological complications of vasculitis. Ann Neurol 1983; 14:155-67.
7. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999; 78:26-37.
8. Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995; 70:337-41.
9. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005; 252:633-41.
10. Puechal X, Said G, Hilliquin P, Coste J, Job-Deslandre C, Lacroix C, Menkes CJ. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995; 38:1618-29.
11. Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003; 74:1267-71.
12. Mahadevan A, Gayathri N, Taly AB, Santosh V, Yasha TC, Shankar SK. Vasculitic neuropathy in HIV infection: A clinicopathological study. Neurol India 2001; 49:277-83.
13. Kemohan JW, Woltman HW. Periarteritis nodosa: A clinicopathologic study with special reference to the nervous system. Arch Neurol Psychiatry 1938; 39:655-86.
14. Kissel JT, Slivka AP, Warmolts JR, Mendell JR. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol 1985; 18:251-7.
15. Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA. Nonsystemic vasculitic neuropathy. Brain 1987; 110:843-53.
16. Davies L, Spies JM, Pollard JD, McLeod JG. Vasculitis confined to peripheral nerves. Brain 1996; 119:1441-8.
17. Collins MP, Periquet MI, Mendell JR, Sahenk Z, Nagaraja HN, Kissel JT. Nonsystemic vasculitic neuropathy: Insights from a clinical cohort. Neurology 2003; 61:623-30.
18. Kararizou E, Davaki P, Karandreas N, Davou R, Vassilopoulos D. Nonsystemic vasculitic neuropathy: A clinicopathological study of 22 cases. J Rheumatol 2005; 32:853-8.
19. Guillevin L, Cordier JF, Lhote F, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40:2187-98.
20. Haubitz M, Schellong S, Gobel U, Schurek HJ, Schaumann D, Koch KM, Brunkhorst R. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study. Arthritis Rheum 1998; 41:1835-44.
21. Pagnoux C, Guillevin L. Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol 2005; 17:41-8.
22. Collins MP, Periquet MI. Non-systemic vasculitic neuropathy. Curr Opin Neurol 2004; 17:587-98.
23. Hawke SH, Davies L, Pamphlett R, Guo YP, Pollard JD, McLeod JG. Vasculitic neuropathy. A clinical and pathological study. Brain 1991; 114:2175-90.
24. Carruthers D, Bacon P. Activity, damage and outcome in systemic vasculitis. Best Pract Res Clin Rheumatol 2001; 15:225-38.
25. Hattori N, Ichimura M, Nagamatsu M, Li M, Yamamoto K, Kumazawa K, Mitsuma T, Sobue G. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 1999; 122:427-39.
26. Jayne D. Evidence-based treatment of systemic vasculitis. Rheumatology 2000; 39:585-95.
27. Guillevin L, Lhote F, Jarrousse B, Fain O. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years. Ann Med Interne (Paris) 1992; 143:405-16.
28. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7:23-32.
29. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: A study in 165 patients. Br J Rheumatol 1988; 27:258-64.
30. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 1998; 37:57-63.
31. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology 2001; 40:492-8.
32. Lane SE, Watts RA, Shepstone L, Scott DG. Primary systemic vasculitis: clinical features and mortality. Q J Med 2005; 98:97-111.
33. Solans R, Bosch JA, Perez-Bocanegra C, Selva A, Huguet P, Alijotas J, Orriols R, Armadans L, Vilardell M. Churg-Strauss syndrome: Outcome and long-term follow-up of 32 patients. Rheumatology 2001; 40:763-71.
34. Langford CA. Vasculitis. J Allergy Clin Immunol 2003; 111:S602-12.
35. Fauci A, Hayes B, Katz P, Wolff S. Wegeners's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Annals of Internal Medicine 1983; 98:76-85.